Correlation Between Diffusion Pharmaceuticals and Ibio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Ibio Inc, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Ibio.

Diversification Opportunities for Diffusion Pharmaceuticals and Ibio

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Diffusion and Ibio is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Ibio go up and down completely randomly.

Pair Corralation between Diffusion Pharmaceuticals and Ibio

Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to under-perform the Ibio. But the stock apears to be less risky and, when comparing its historical volatility, Diffusion Pharmaceuticals is 3.67 times less risky than Ibio. The stock trades about -0.11 of its potential returns per unit of risk. The Ibio Inc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,240  in Ibio Inc on August 29, 2024 and sell it today you would lose (977.00) from holding Ibio Inc or give up 78.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy31.45%
ValuesDaily Returns

Diffusion Pharmaceuticals  vs.  Ibio Inc

 Performance 
       Timeline  
Diffusion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diffusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Diffusion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Ibio Inc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.

Diffusion Pharmaceuticals and Ibio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diffusion Pharmaceuticals and Ibio

The main advantage of trading using opposite Diffusion Pharmaceuticals and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.
The idea behind Diffusion Pharmaceuticals and Ibio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities